These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30473747)

  • 41. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
    Nishie W
    J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions.
    Sun XK; Chen JF; Shen H
    Arch Dermatol Res; 2016 Aug; 308(6):429-36. PubMed ID: 27221282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
    Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
    Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies.
    Lo Schiavo A; Ruocco E; Brancaccio G; Caccavale S; Ruocco V; Wolf R
    Clin Dermatol; 2013; 31(4):391-399. PubMed ID: 23806156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
    Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
    J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoglobulin G subclass distribution of bullous pemphigoid autoantibodies and complement fixation studies.
    Al-Karawi KS
    Saudi Med J; 2002 Dec; 23(12):1492-5. PubMed ID: 12518199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.
    Cugno M; Tedeschi A; Borghi A; Bucciarelli P; Asero R; Venegoni L; Griffini S; Grovetti E; Berti E; Marzano AV
    PLoS One; 2015; 10(6):e0129456. PubMed ID: 26057532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chemotactic activity in the fluid of bullous pemphigoid blisters].
    Diáz Pérez JL; Jordon RE
    Med Cutan Ibero Lat Am; 1975; 3(6):465-70. PubMed ID: 778510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.
    Provost TT; Tomasi TB
    J Clin Invest; 1973 Jul; 52(7):1779-87. PubMed ID: 4352464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Localized Bullous Pemphigoid Following Orthopedic Surgery.
    Milani-Nejad N; Rzepka P; Zirwas MJ; Kaffenberger J
    J Clin Aesthet Dermatol; 2021 Apr; 14(4):36-37. PubMed ID: 34055186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metronidazole-Induced Bullous Pemphigoid: A Case Report.
    Moitra S; Sen S; Banerjee I; Sikder A; Das P
    J Clin Diagn Res; 2015 Dec; 9(12):FD01-3. PubMed ID: 26816913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levetiracetam-induced bullous pemphigoid in a young adult woman.
    Santaliz-Ruiz LEI; Blanco-Cintron ME; Caro-Muñiz AP; Villa J; Martin-Garcia RF
    JAAD Case Rep; 2022 Mar; 21():56-58. PubMed ID: 35146103
    [No Abstract]   [Full Text] [Related]  

  • 54. A distinct cutaneous microbiota profile in autoimmune bullous disease patients.
    Miodovnik M; Künstner A; Langan EA; Zillikens D; Gläser R; Sprecher E; Baines JF; Schmidt E; Ibrahim SM
    Exp Dermatol; 2017 Dec; 26(12):1221-1227. PubMed ID: 28418589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid.
    Walmsley N; Hampton P
    J Dermatol Case Rep; 2011 Dec; 5(4):74-6. PubMed ID: 22408707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depression and Anxiety in Patients with Bullous Pemphigoid: Impact and Management Challenges.
    Kluger N; Pankakoski A; Panelius J
    Clin Cosmet Investig Dermatol; 2020; 13():73-76. PubMed ID: 32021371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of Psoriasis and Bullous Diseases.
    Dainichi T; Kabashima K
    Front Med (Lausanne); 2018; 5():222. PubMed ID: 30135860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature.
    Bech R; Kibsgaard L; Vestergaard C
    Front Med (Lausanne); 2018; 5():238. PubMed ID: 30234116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower Extremity Salvage in the Setting of Bullous Pemphigoid Exacerbation: A Case Report.
    Pollock SE; Rice SM; Ferree SD; Friedstat J; Eberlin K; Kourosh AS
    Plast Reconstr Surg Glob Open; 2021 Aug; 9(8):e3722. PubMed ID: 34476147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of bullous pemphigoid induced by torsemide.
    Wurtz P; Borucki R; Georgesen C
    JAAD Case Rep; 2022 Aug; 26():95-97. PubMed ID: 35942352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.